New shot aims to arm bodies against deadly sudan ebola virus
NCT ID NCT06803342
Summary
This study is testing a new vaccine designed to protect against the Sudan strain of the Ebola virus. Researchers are enrolling 200 healthy adults to receive either the experimental vaccine or a placebo shot. The main goals are to check if the vaccine is safe and to see if it triggers a strong immune response that could fight off the virus.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EBOLA SUDAN VIRUS DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Optimal Research; LLC
Melbourne, Florida, 32934, United States
-
Synexus Clinical Research US, Inc.
Phoenix, Arizona, 85020, United States
-
Synexus Clinical Research US, Inc.
Chicago, Illinois, 60602, United States
-
Synexus Clinical Research US, Inc.
San Antonio, Texas, 78229, United States
Conditions
Explore the condition pages connected to this study.